In a universe of possibilities, WE SEE THINGS DIFFERENTLY WE […]
Location: United States, California, South San Francisco
Total raised: $90M
Investors 5
| Date | Name | Website |
| 18.02.2022 | RA Capital... | racap.com |
| 24.09.2023 | Sofinnova ... | sofinnova.... |
| 30.08.2023 | OrbiMed | orbimed.co... |
| 08.08.2023 | Catalio Ca... | cataliocap... |
| 23.03.2022 | New Leaf V... | nlvpartner... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 05.09.2023 | Series C | $90M | - |
Mentions in press and media 8
| Date | Title | Description |
| 02.10.2025 | Star Therapeutics Raises $125M Series D Round | SOUTH SAN FRANCISCO, CA, Star Therapeutics has announced an oversubscribed $125 million Series D financing. >> Click here for more funding data on Star Therapeutics >> To export Star Therapeutics funding data to PDF and Excel, ... |
| 01.10.2025 | Star Therapeutics Raises $125M in Series D Financing | Star Therapeutics, a San Francisca, CA-based clinical stage biotechnology company discovering and developing antibodies for bleeding disorders and other diseases, raised $125M Series D funding. The round was co-led by Sanofi Ventures and Vi... |
| 05.09.2023 | Star Therapeutics Raises $90 Million Financing to Accelerate its Pipeline of Novel Antibody Therapies | - |
| 05.09.2023 | Star Therapeutics Raises $90 Million Financing to Accelerate Its Pipeline of Novel Antibody Therapies and Growth of Its Portfolio Companies | - |
| 05.09.2023 | Investors shower Star Therapeutics with $90M for constellation of biotechs, antibody therapies | Investors have showered Star Therapeutics with $90 million to grow its portfolio companies and develop new antibody drugs for diseases with high unmet need. Sofinnova Investments led the oversubscribed series C round and was joined by new i... |
| 05.09.2023 | Star Therapeutics Lands $90M to Expand Its Drug Discovery Universe | The research of Star Therapeutics has spawned two startup subsidiaries, each with a clinical-stage program. Now the startup creator has $90 million to continue clinical development and to form new biotech companies in hematology and immunol... |
| 05.09.2023 | Star Therapeutics Raises $90M in Series C Funding | Star Therapeutics, a South San Francisco, CA-based biotechnology company advancing antibody therapies, raised $90M in Series C funding. The round was led by Sofinnova Investments, and included new investors Qatar Investment Authority (QIA),... |
| - | Star Therapeutics | “In a universe of possibilities, WE SEE THINGS DIFFERENTLY WE […]” |